Results 141 to 146 of about 5,463 (146)

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial

Lancet Oncology, The, 2018
Petra Langerbeins, Othman Al-Sawaf, Clemens-Martin Wendtner   +2 more
exaly  

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment

OncoImmunology, 2018
Franck Morschhauser, Roch Houot, Cedric Menard   +2 more
exaly  

Obinutuzumab effective against treatment-refractory NHL

Nature Reviews Clinical Oncology, 2016
exaly  

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

New England Journal of Medicine
exaly   +2 more sources

Obinutuzumab Treatment of Follicular Lymphoma

New England Journal of Medicine, 2017
exaly  

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

Lancet Oncology, The
exaly